ConditionSkin, hair & nails

Congenital Melanocytic Nevus (Birthmark Mole)

A congenital melanocytic nevus (CMN) is a mole that is present at birth or appears in the first months of life. It is made of pigment cells (melanocytes) that clustered during development in the womb. About 1 in 100 babies has a small one. Most are harmless and grow in proportion with the child. Very large ones, and babies with many nevi, carry a higher risk of melanoma and of pigment cells in the brain and spinal cord lining, so they need specialist follow-up.

Also called: Congenital mole, congenital nevus, CMN, giant congenital nevus, birthmark mole

At a glance

What it is
A mole present at birth or appearing in early infancy.
How common
About 1 in 100 newborns. Large or giant ones affect about 1 in 20,000.
Sizes
Small (under 1.5 cm), medium (1.5 to 20 cm), large (20 to 40 cm) and giant (over 40 cm), based on projected adult size.
Risks
Melanoma risk is very low for small and medium nevi and higher for large and giant ones.
Management
Regular skin checks and photos. MRI for babies with multiple nevi. Surgery in selected cases.

When to get help

See a doctor within a day or two

  • A new lump, nodule, bleeding sore or rapid change of color within a congenital nevus
  • In a child with a large or multiple congenital nevi: new headaches, vomiting, seizures, a rapidly growing head, or developmental regression

Book a routine appointment

  • A newborn with a large congenital nevus, or more than one congenital nevus at birth, for referral to a pediatric dermatologist
  • Itching, pain, or a texture change in a nevus
  • A nevus over the spine, especially with a dimple, hair tuft or lump
  • Concerns about appearance, comfort or emotional impact

Usually safe to manage at home

  • A small, stable congenital mole that grows in proportion with the child, with photos taken a few times a year

What a congenital melanocytic nevus is

Melanocytes are the pigment-producing cells of the skin. In a CMN, an early genetic change in a single developing cell (most often in the NRAS gene) causes melanocytes to multiply and cluster before birth. These changes are not inherited from the parents and are not caused by anything the parents did during pregnancy.

Size classification

Doctors classify CMN by the size the nevus is expected to reach in adulthood. A nevus on a baby's body grows roughly 1.7 times on the head and about 3 times on the trunk and legs by adulthood.

CategoryProjected adult sizeNotes
SmallUnder 1.5 cmMost common, very low risk
Medium1.5 to 20 cmLow risk
Large20 to 40 cmHigher risk, specialist follow-up
GiantOver 40 cmHighest risk, often with many smaller "satellite" nevi

The number of nevi matters as much as size. A baby born with two or more congenital nevi (often a large one plus satellites) has a higher chance of involvement of the brain and spinal cord.

Appearance

  • light to dark brown or black, sometimes with a mix of colors
  • flat at birth, often becoming raised, thicker or bumpy with age
  • coarse dark hairs commonly grow from the nevus
  • may lighten over time in some children
  • large nevi can have a textured, pebbly or lumpy surface and may itch or feel dry

Changes in color, thickness and hair during childhood are expected and usually harmless, unlike the pattern of ordinary moles that appear later in life. Sudden new nodules are not.

Risks

Melanoma

Melanoma can develop in or near a CMN, or rarely in the brain or spinal cord.

  • Small and medium CMN: lifetime melanoma risk is very low, likely well under 1 in 100, similar to or slightly above that of other moles. Melanoma in these nevi, if it occurs, usually appears after puberty and at the edge.
  • Large and giant CMN: lifetime risk is higher, estimated at about 2 to 5 in 100 in many studies, with about half of these melanomas occurring in the first 5 years of life. Risk is highest with giant nevi on the trunk and many satellite nevi.

Neurocutaneous melanosis

In some children with large or multiple CMN, melanocytes are also present in the lining of the brain and spinal cord. This can be silent or can cause hydrocephalus, seizures and developmental problems. Guidance in many centers recommends a single MRI of the brain and spine, ideally in the first months of life, for babies born with more than one congenital nevus.

Emotional and social impact

Large or visible nevi can affect self-esteem and social life as children grow. Psychological support and contact with family groups help many families.

Monitoring

  • Take dated photos of the nevus, with a ruler for scale, every 3 to 6 months in early childhood.
  • Examine the nevus by looking and feeling for new lumps, especially in large nevi.
  • Regular dermatology review: typically yearly for small nevi, more often for large or giant nevi.
  • Sun protection: clothing, shade and broad-spectrum sunscreen. See skin cancer screening for adult checks.

See dermatology surveillance for how routine skin monitoring works.

Treatment

There is no single right approach. Decisions depend on size, location, risk, symptoms, appearance and family preferences.

  • Observation: appropriate for most small and medium nevi.
  • Surgical excision: for small to medium nevi that are hard to monitor, change, or cause concern about appearance. Often done in later childhood under local anesthetic.
  • Staged excision, tissue expanders and skin grafts: for large nevi. Removing all the cells is often impossible, and surgery does not eliminate melanoma risk, especially in the brain. Decisions are made with plastic surgeons experienced in CMN.
  • Laser and dermabrasion: may lighten color but leave deeper cells. They are used selectively and can make monitoring harder.
  • Symptom care: moisturizers and anti-itch treatment for dry, itchy nevi.
  • Biopsy: for any new nodule or concerning change.

Targeted medicines that act on the NRAS pathway are being studied for large CMN.

Outlook

Most people with small or medium CMN have no complications. Children with large or giant nevi need lifelong follow-up but most never develop melanoma. Early specialist assessment and family support improve both medical and emotional outcomes.

Frequently asked questions

What is a congenital melanocytic nevus?

It is a mole that is present at birth or appears in the first months of life. It forms when pigment cells cluster during development in the womb. Most are small and harmless, but large ones need specialist follow-up.

Does a congenital nevus turn into melanoma?

Rarely for small and medium nevi. Large and giant congenital nevi carry a higher lifetime melanoma risk, estimated at a few percent. Regular checks for new lumps or rapid changes help catch problems early.

Should a congenital mole be removed?

Not always. Most small and medium congenital moles can be watched. Removal may be considered if a mole is changing, hard to monitor, causes symptoms, or affects appearance. Large nevi need individual planning with a specialist team.

Why does my baby need an MRI for a birthmark mole?

Babies born with more than one congenital nevus, or with a large nevus plus satellites, have a higher chance of pigment cells in the brain and spinal cord lining. A screening MRI in infancy checks for this.

Is a congenital melanocytic nevus inherited?

No. It is caused by a genetic change that happens by chance in one cell during development in the womb. It is not passed down from parents and does not usually recur in siblings.

Sources

This guide was written from current patient and clinical guidance, including:

  • American Academy of Dermatology: Congenital nevi
  • Society for Pediatric Dermatology: Congenital melanocytic nevi patient handout
  • British Association of Dermatologists: Congenital melanocytic naevi patient information
  • Nevus Outreach: Congenital nevus information for families
  • DermNet: Congenital melanocytic naevus